Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia.
about
A pilot study of an online cognitive rehabilitation program for executive function skills in children with cancer-related brain injuryDeveloping interventions for cancer-related cognitive dysfunction in childhood cancer survivorsImpact of chemotherapy for childhood leukemia on brain morphology and function.Symptoms of attention-deficit/hyperactivity disorder in long-term survivors of childhood leukemiaNeuropsychological outcomes of standard risk and high risk patients treated for acute lymphoblastic leukemia on Dana-Farber ALL consortium protocol 95-01 at 5 years post-diagnosis.Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia: associations with physical performance and chemotherapy doses.Survivors of standard risk acute lymphoblastic leukemia do not have increased risk for overweight and obesity compared to non-cancer peers: a report from the Children's Oncology GroupMathematics intervention for prevention of neurocognitive deficits in childhood leukemiaNeurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence?Neurodevelopmental functioning in very young children undergoing treatment for non-CNS cancersNeurocognitive Predictors of Academic Outcomes Among Childhood Leukemia SurvivorsNeurocognitive and Patient-Reported Outcomes in Adult Survivors of Childhood Osteosarcoma.Effect of high dose cytosine arabinoside on quantitative EEG in patients with acute myeloid leukemia.The Association Between Motor Skills and Academic Achievement Among Pediatric Survivors of Acute Lymphoblastic Leukemia.Overcoming pharmacologic sanctuaries.Milestones in the curability of pediatric cancersGenetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemiaChildhood cancer survivorship: an update on evolving paradigms for understanding pathogenesis and screening for therapy-related late effects.Children's Oncology Group's 2013 blueprint for research: survivorship and outcomes.Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study.Chemotherapy-related changes in central nervous system phospholipids and neurocognitive function in childhood acute lymphoblastic leukemia.Acute cognitive and behavioral effects of systemic corticosteroids in children treated for inflammatory bowel disease.Chemotherapy Pharmacodynamics and Neuroimaging and Neurocognitive Outcomes in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia.Disruption of learning processes by chemotherapeutic agents in childhood survivors of acute lymphoblastic leukemia and preclinical modelsChildren's Oncology Group's 2013 blueprint for research: cancer control and supportive care.Children's Oncology Group's 2013 blueprint for research: behavioral science.Motor functioning during and following treatment with chemotherapy for pediatric acute lymphoblastic leukemia.Neurocognitive evaluation of long term survivors of atypical teratoid rhabdoid tumors (ATRT): The Canadian registry experience.Monitoring and Assessment of Neuropsychological Outcomes as a Standard of Care in Pediatric Oncology.Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.A meta-analysis of the neuropsychological effects of chemotherapy in the treatment of childhood cancer.Brain size and neuropsychological functioning in long-term survivors of pediatric acute lymphoblastic leukemia.Longitudinal language outcomes following intrathecal chemotherapy for acute lymphoblastic leukaemia.Development of figurative language skills following central nervous system-directed chemotherapy delivered in early childhood.Chronic Health Conditions and Neurocognitive Function in Aging Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study.The Behavior Rating Inventory of Executive Function (BRIEF) to Identify Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors At Risk for Neurocognitive Impairment.The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia.
P2860
Q24606514-E0335E21-A2F1-4898-AF64-99BE52DEAC39Q26825655-8300FD1C-CB0F-45D3-9796-5EED15C05DCCQ35050321-730B9CB2-DEA1-430A-AE5B-BF02C4B2584BQ35119007-913613D8-767E-431E-803B-9B6BC439F560Q35293193-3FB5A9C2-7D58-4C7F-9ECB-3FC6C3EBCA9EQ35402351-07F8ACF6-10B0-4F21-A318-7B443E4D4403Q35513785-84122EB3-DB7C-42C1-BB65-0FFFA27BBDCBQ35635557-B773E3E7-FF7C-4741-97CE-8B87DAB7EE0AQ35736047-E6216E3D-39D8-4DD2-9D6D-684564074C64Q36054142-659780FC-DC3D-4DE3-B7A2-DBBBD6FF0669Q36445713-858FB0B1-BA93-47DB-BAF9-A41124B82BE9Q36576663-D2C45BD8-FDD2-4AFE-BB77-0724E6B1DDF1Q36723848-FA9553D0-E7F1-42E5-BDF1-8D37C8859F73Q36855070-81702DE6-0A0F-4BC6-BFEC-89702B029033Q36915933-EF45A437-FE4C-402A-BD6D-3BFCD046718CQ36925083-E56DAC89-3F90-4E7F-BF30-3055B8723D34Q37065825-B0F38686-A2AA-4858-8884-4B17C1C0E9B5Q37167767-AB5C0CDF-1F9D-436F-B6D9-4A1E63F73C78Q37237505-4A269C1D-56B6-4517-9CAC-F8C2EBB3B2DDQ37348625-8FADAD16-E350-4C01-9FFE-67DB2FBAE8C3Q37352921-B3B25E90-4548-4242-A989-92C5DF6FC0F4Q37626854-3C93DD71-EF56-4036-A2C7-39BFC25E5D07Q37659020-6296F83D-2FBC-412B-ACAC-17322C2A60DAQ37879488-4D4397EA-3C0E-426E-A5E1-D439EAE129A6Q38068800-3D2473C7-93D8-453C-BAE7-96A8875E50B0Q38068835-2A953638-8506-495B-B328-AF3CB217F181Q38101016-3953F33F-D671-4471-9B7F-EB3EE0F3D5DEQ38383177-E29CB20E-B572-4B2E-977D-FB6357733503Q38678301-1B7BC805-A051-4DDE-862E-B282690F6DCDQ39303835-1B9276AC-A817-44EF-862C-F9915BE74939Q39555029-18862EBB-054E-45D3-AF4B-0459496FE17BQ40033066-93C17285-E111-4275-8443-79F23258798BQ44326589-E4B976EB-36F2-4349-8323-A332E3F136F0Q45397814-4C67713F-E6A8-4777-AEC9-490DA0AC7B80Q47229711-FFA42E6A-C8B9-4D74-AF54-5CC5FBE7C890Q47828511-CF590A3C-385F-4D42-B86C-69B0727EBC56Q48086635-79A1705B-F9F7-48B8-812F-C92AE9013637
P2860
Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Comparison of neurocognitive f ...... acute lymphoblastic leukemia.
@en
Comparison of neurocognitive f ...... acute lymphoblastic leukemia.
@nl
type
label
Comparison of neurocognitive f ...... acute lymphoblastic leukemia.
@en
Comparison of neurocognitive f ...... acute lymphoblastic leukemia.
@nl
prefLabel
Comparison of neurocognitive f ...... acute lymphoblastic leukemia.
@en
Comparison of neurocognitive f ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P356
P1476
Comparison of neurocognitive f ...... d acute lymphoblastic leukemia
@en
P2093
Bruce Bostrom
David Breiger
James Dziura
Linda Stork
Megan Nicoletti
Pim Brouwers
Thomas Kaleita
Veronika Northrup
P2860
P304
P356
10.1200/JCO.2009.23.5408
P407
P577
2009-11-02T00:00:00Z